BULNEXO

Sublingual tablet, 2mg/0.5mg
RxActive license

Active substance (INN)

buprenorphinenaloxone

Pharmaceutical form

Pharmaceutical formSublingual tablet
Strength2mg/0.5mg
PackagingUkupno 7 sublingvalnih tableta u blisteru djeljivom na pojedinačne doze (1x (7x1)) u kartonskoj kutiji
ManufacturerAlkaloid AD Skopje, North Macedonia
Therapeutic groupNervous system (N07BC51)
Marketing authorization holderDRUŠTVO "ALKALOID" D.O.O. PODGORICA
Authorization dateMarch 4, 2026

Analogs in Montenegro

8

Other medicines with the same active substance

BULNEXORx
Sublingual tablet, 2mg/0.5mgAlkaloid AD Skopje
BULNEXORx
Sublingual tablet, 8mg/2mgAlkaloid AD Skopje
BULNEXORx
Sublingual tablet, 8mg/2mgAlkaloid AD Skopje
BUPRENORFIN ALKALOIDRx
Sublingual tablet, 2mgAlkaloid AD Skopje
BUPRENORFIN ALKALOIDRx
Sublingual tablet, 2mgAlkaloid AD Skopje
BUPRENORFIN ALKALOIDRx
Sublingual tablet, 8mgAlkaloid AD Skopje
BUPRENORFIN ALKALOIDRx
Sublingual tablet, 8mgAlkaloid AD Skopje
BUPRENORFIN ALKALOIDRx
Sublingual tablet, 0.4mgAlkaloid AD Skopje
Source: CInMED register